CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,725 enrolled
Drug / intervention
Prognostic factors of severe COVID-19other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05102708
NCT05102708N/ACompleted
CompareCT.gov

Study of COVID-19 Prognostic Factors in Hospitalized Patients

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·observational·Posted Nov 1, 2021·Updated Sep 6, 2022

In Brief

An observational study evaluating Prognostic factors of severe COVID-19 for COVID-19. Completed, enrolled 3,725 participants across 1 site.

Detailed Summary

Severe COVID-19 prognostic factors have been studied worldwide throughout the pandemic, but there is considerable variability. Therefore, the investigators will summarize the identified prognostic factors in the international literature and will conduct a retrospective cohort study to identify the prognostic factors of severe COVID-19 in hospitalized patients of the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain) between March 2020 and February 2021, compare them with those mentioned in the international literature and establish those most adequate to our population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 1, 2021
Enrollment StartNov 25, 2021
Primary CompletionDec 31, 2021
Study CompletionMay 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 4.7 years ago

Interventions

Prognostic factors of severe COVID-19other

prognostic factors: patients´ epidemiological characteristics (such as age, sex), comorbidities, length of hospitalization, critical care admission, treatments received, laboratory results, vital signs.